Post by
swissinc on Jun 02, 2003 1:36pm
Start Buying on weakness?
ZMH's reconstructive implant sales which represent over 70%of revenues ,have been driving results.ZMH is the most highly leveraged to the strong industry backdrop and also has the best implant growth profile given its mix and sales organization.
ZMH's hip implant platform should grow faster than its competitors' owing to its focus on the technologically advanced porous coated hip implants,its revision porfolio,and its leadership in the minimally invasive market.